COMPASS Pathways (CMPS)
NASDAQ: CMPS
· Real-Time Price · USD
3.99
0.09 (2.31%)
At close: May 13, 2025, 3:59 PM
2.31% (1D)
| Bid | 3.9 |
| Market Cap | 370.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -137.8M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -2.01 |
| Forward PE | -2.71 |
| Analyst | Buy |
| Ask | 4.07 |
| Volume | 76,657 |
| Avg. Volume (20D) | 1,004,756 |
| Open | 3.92 |
| Previous Close | 3.90 |
| Day's Range | 3.91 - 4.03 |
| 52-Week Range | 2.49 - 8.54 |
| Beta | 2.28 |
About CMPS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+5.95%
Compass Pathways shares are trading higher. The co...
Unlock content with
Pro Subscription
6 months ago
-23.1%
Compass Pathways shares are trading lower after the company announced it pushed its topline data readout from its COMP005 Phase 3 trial to Q2 2025 and its COMP006 data will be announced after the 26-week time point.
2 weeks ago · businesswire.com
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal...
